NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hesperos Inc.

Hesperos Inc.

Private
Orlando, FloridaHealthcare & Life Scienceshttps://hesperosinc.com/

Last Round

Convertible Debt

Sep 8, 2023

Total Funding Raised

$14.82M

Company Overview

Hesperos Inc. is a biotechnology company that provides safety and efficacy testing services using its Human-on-a-Chip® platform for the pharmaceutical, cosmetic, and food industries.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Data as a Service

AI Layer

Application

Keywords

organ-on-a-chipHuman-on-a-Chipcontract research organizationCROmicrophysiological systemsanimal testing alternativedrug discoverypreclinical CROsafety testingefficacy testingMPSdisease modelingbody-on-a-chipADME analysisPK/PD modelingrare disease research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hesperos Inc. Comparables

Compare Hesperos Inc. with similar companies based on industry and business-model similarity.

Hesperos Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Xellar Biosystems
86%
MEPSGEN
85%
Xellar Biosystems
85%

Hesperos Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtSep 8, 2023
IPOJul 13, 2022
GrantAug 25, 2021
DebtMar 1, 2020
DebtApr 1, 2019
Grant
Sep 6, 2018

Key People

Founding team and executive leadership

James Kronauge

Chief Executive Officer

Executive Team

Lawrence Florin

CEO

Executive Team

Hesperos Inc. Investors

Notable investors and investment history

Hesperos Inc. investors
InvestorRounds
NIH RADxGrant
Btomorrow VenturesConvertible Debt
National Center for Advancing Translational SciencesGrant
ThinkEquityIPO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 50% MoM.

  • Sep 8, 2023

    $6.3M round led by Btomorrow Ventures.

Hesperos Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hesperos Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hesperos Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersOrlando, Florida
Employee Range62
Year Founded2015
Last FundingSep 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.